Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 7, 1999, Pages 691-699

  Ek, A ^a   Larsson, K ^a   Siljerud, S ^a   Palmberg, L ^a  

^a NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

Author keywords

A549 cells; Glucocorticoids; Interleukin 6; Interleukin 8; Tumor necrosis factor

Indexed keywords

BUDESONIDE; CYTOKINE; FLUTICASONE; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DUST; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; ANDROSTADIENES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CYTOKINES; DUST; EPITHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; SWINE; TUMOR CELLS, CULTURED;

EID: 0032838619     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00087.x     Document Type: Article

References (41)

1. Sibille Y, Reynolds H. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990;141:471-501.
2. Davies RJ, Devalia JL. Epithelial cells. Br Med Bull 1992;48:85-96.
3. Barbara JAJ, van Ostade X, Flopez A. Tumor necrosis factor-alpha (TNF-α): the good, the bad and potentially very effective. Immunol Cell Biol 1996;74:434-443.
4. Martin LD, Rochelle LG, Fischer BM, Krunkosky TM, Adler KB. Airway epithelium as an affector of inflammation: molecular regulation of secondary mediators. Eur Respir J 1997;10:2139-2146.
5. Lohmann-Matthes M-L, Steinmüller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994;7:1678-1689.
6. Warren JS. Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci 1990;28:37-59.
7. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
8. Heinrich PC, Castell JV, Andus T. Interleukin 6 and the acute phase response. Biochem J 1990;265:621.
9. Wong GG, Clark SC. Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1988;9:137-139.
10. Leonard EJ, Yoshimura T. Neutrophil attractant/activation protein-1 [NAP-1{interleukin-8}]. Am J Respir Cell Mol Biol 1990;2:479-486.
11. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989;243:1464-1466.
12. Warringa RAJ, Koenderman J, Kok PTM, Kreukniet J, Matsushima K. Modulation and induction of cosinophil chemotaxis by granulocyte-macrophage colony factor and interleukin-3. Blood 1991;77:2694-2700.
13. Larsson K, Eklund AG, Hansson L-O, Isaksson B-M, Malmberg PO. Swine dust causes intense airways inflammation in healthy subjects. Am J Respir Crit Care Med 1994;150:973-977.
14. Larsson B-M, Palmberg L, Malmberg PO, Larsson K. Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid. Thorax 1997;52:638-642.
15. Wang Z, Malmberg P, Larsson P, Larsson B-M, Larsson K. Time course of IL-6 and TNF-α in serum following inhalation of swine dust. Am J Respir Crit Care Med 1996;153:147-152.
16. Wang Z, Larsson K, Palmberg L, Malmberg P, Larsson P, Larsson L. Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J 1997;10:381-387.
17. Schwiebert LA, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol 1996;97:143-152.
18. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993;45 Suppl 1:S3-S7.
19. Lane SJ, Lee TH. Mechanism and detection of glucocorticoid insensitivity in asthma. Allergy Clin Immunol Int 1997;9:165-173.
20. Bloom JW. Molecular pharmacology of glucocorticoids. Clin Asthma Rev 1997;1:99-107.
21. Larsson K, Tomling G, Gavhed D, Müller-Suur C, Palmberg L. Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects. Eur Respir J 1998;12:825-830.
22. Ryrfeldt Å, Andersson P, Edsbäcker S, Tönnesson M, Davies D, Pauwels R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 1982;Suppl 122:86-95.
23. van der Bosch JMM, Westmann CJJ, Aumann J, Edsbäcker S, Tönnesson M, Selroos O. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos 1993;14:445-459.
24. Esmailpour N, Högger P, Rabe KF, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997;10:1496-1499.
25. Kerrebijn KF. Long-term drug treatment of asthma in children. Lung 1990;168 (Suppl):142-153.
26. Palmberg L, Larsson B-M, Malmberg P, Larsson K. Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax 1998;53:260-264.
27. Linden M, Brattsand R. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1 beta, and IL-6. Pulm Pharmacol 1994;7:43-47.
28. 2 and dexamethasone. Am J Respir Cell Mol Biol 1992;6:75-81.
29. Fattal-German M, Le Roy Laduric F, Lecerf F, Berrih-Aknin S. Expression of ICAM-1 and TNF-α in human alveolar macrophages from lung-transplant recipients. Ann N Y Acad Sci 1996;796:138-148.
30. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Tarraf H, Davies RJ. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-α and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J 1994;7:2109-2116.
31. Kwon OJ, Au BT, Collins PD, et al. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology 1994;81:389-394.
32. Persson CGA, Pipkorn U. Glucocorticoids. Chem Immunol 1990;49:264-277.
33. Streiter RM, Remick DG, Lynch JP III, et al. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am J Respir Cell Mol Biol 1989;1:57-63.
34. Levine SJ, Larivée P, Logun C, Angus CW, Shelhamer JH. Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. Am J Physiol 1993;265:L360-L368.
35. Kwon OJ, Au BT, Collins PD, et al. Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am J Physiol 1994;267:L398-405.
36. Adcock IM, Brown RC, Barnes PJ. Tumor necrosis factor α causes retention of activated glucocorticoid receptor within the cytoplasm of A549 cells. Biochem Biophys Res Commun 1996;225:545-550.
37. Hughes SC, Vardey CJ, Whelan CJ. Inhaled fluticasone propionate is a potent inhibitor of PAF-induced eosinophil accumulation in guinea-pig lung. Eur Respir J 1993;6 Suppl 17:585s.
38. English AF, Neate MS, Quint DJ, Sareen M. Biological activities of some corticosteroids used in asthma. Am J Respir Crit Care Med 1994;149 Suppl 4, Pt 2:A212.
39. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52 Suppl 39:1-34.
40. Fuller R, Johnson M, Bye A. Fluticasone propionate - an update on preclinical and clinical experience. Respir Med 1995;89 Suppl A:3-18.
41. Johnson M. The anti-inflammatory profile of fluticasone propionate. Allergy 1995;50 Suppl 231:11-14.